Med Sci Monit 17(6):PI15PI23 Somi MH, Fatahi E, Panahi J, Havasian MR (2014) Data from a randomized and controlled trial of L Carnitine prescription for the treatment for Non-Alcoholic Fatty Liver Disease
LRE mechanistically elevated antioxidant enzymes such as GPX-4, Prdx-5, HO-1, and SOD-2, which are essential for alleviating oxidative damage
The combination offers synergistic benefits for energy, longevity, and detoxification
doi: 10.1183/13993003.02245-2021 143 BucciarelliVNasiMBiancoFSeferovicJIvkovicVGallinaSet al
Ser supplementation improves both femur length and bone mineral density in piglets, while significantly increasing body length growth rate (46)
Since many diseases are localized, delivery of a medication to the disease site serves well for the purpose of disease treatment